The S&P 500 nudged to a record high on Thursday, shrugging off weak tech earnings to close above its level in October, a high point before worries over corporate spending on artificial intelligence ...

Dividend Kings remain largely overvalued, but six—including MO, UVV, HRL, KVUE, CDUAF, and UBSI—are now fairly priced with ...

If you’ve ever turned on a finance show or opened an investing app, you’ve probably seen short strings of letters next to ...

(WETM) – The stock market is constantly changing, with many factors playing a role in its every move. 18 News’ Jah’Neyce ...

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce that in accordance with its ...

The Rs 922-crore IPO had attracted strong investor demand, getting subscribed nearly 102 times during the bidding window from ...

When Jim Cramer speaks about personal finance, many investors pay close attention. His track record with individual stock ...

The U.S. stock market neared its all-time high after the Federal Reserve cut its main interest rate to bolster the job market ...

Dyne Therapeutics, Inc.’s 2026 outlook with key DYNE-101/251 data, FDA submission plans, and extended cash runway. Click for ...

Walmart could receive an additional $20 billion in investment by joining the Nasdaq’s QQQ index.

Investing.com -- Akari Therapeutics PLC (NASDAQ:AKTX) stock gained 7.9% in premarket trading Tuesday after the company released preclinical data showing its novel antibody-drug conjugate AKTX-101 ...

Just a few weeks ago, the stock market stumbled over fears that artificial intelligence stocks might be in a bubble. Now stocks are back within reach of a record high.